Signal #144069 · SEC 8-K

$IRWD SEC Filing Alert & Real-Time AI Stock Impact Analysis

Public T0 SEO entry. Full AI score & bullets unlock after 4 hours (VIP: instant).

FAQ: $IRWD filing catalyst

Why did $IRWD trigger an AI stock catalyst alert?

$IRWD triggered a Stock Catalyst AI alert on 2026-11-05 00:00:00 UTC for a SEC 8-K filing (AI Score: +6.8/10). Headline: Ironwood Pharmaceuticals Raises Full-Year 2026 Guidance Following Strong Q3 Results. Key points: - Total Q3 revenue rose to $133M with GAAP net income of $60M ($0.36 per share vs $0.25 prior year). - Full-year 2026 total revenue guidance lifted to $485M–$510M and adjusted EBITDA expected above $350M. - U.S. LINZESS net sales guidance raised to $1.20B–$1.25B, up over 35% year-over-year.

How did $IRWD stock react after the SEC filing?

After the SEC 8-K for $IRWD, observed market reaction: T0 price $3.77. Past moves do not guarantee future results.

Where can I get real-time $IRWD SEC filing alerts?

Stock Catalyst AI pushes real-time SEC 8-K alerts for $IRWD via Telegram and the VIP Web Terminal from €10/month.

$IRWD

$IRWD – Ironwood Pharmaceuticals Raises Full-Year 2026 Guidance Following Strong Q3 Results

IRONWOOD PHARMACEUTICALS INC

2026-11-05 00:00:00 UTC · SEC 8-K · All $IRWD

Unlocked archive · Analyzed in <2s at T0

Bullish AI Sentiment (+6.8 / 10)

Total Q3 revenue rose to $133M with GAAP net income of $60M ($0.36 per share vs $0.25 prior year).
Full-year 2026 total revenue guidance lifted to $485M–$510M and adjusted EBITDA expected above $350M.
U.S. LINZESS net sales guidance raised to $1.20B–$1.25B, up over 35% year-over-year.

Unlock Live VIP Terminal & Telegram – €10/mo Original filing →